Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to 0.44.

  • Amphastar Pharmaceuticals' Asset Utilization Ratio fell 749.28% to 0.44 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44, marking a year-over-year decrease of 749.28%. This contributed to the annual value of 0.47 for FY2024, which is 1711.91% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Asset Utilization Ratio is 0.44, which was down 749.28% from 0.45 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Asset Utilization Ratio registered a high of 0.68 during Q1 2023, and its lowest value of 0.41 during Q3 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Asset Utilization Ratio value was 0.5 (recorded in 2023), while the average stood at 0.54.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 1773.16% in 2021, then plummeted by 3845.82% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.66 in 2021, then grew by 2.69% to 0.68 in 2022, then crashed by 37.97% to 0.42 in 2023, then grew by 11.22% to 0.47 in 2024, then decreased by 5.97% to 0.44 in 2025.
  • Its Asset Utilization Ratio was 0.44 in Q3 2025, compared to 0.45 in Q2 2025 and 0.46 in Q1 2025.